< Back to companies
FUSE-AI

FUSE-AI

Zürich, Switzerland

With the use of artificial intelligence in medicine, especially in the imaging methods of radiology such as the MRI, we set radiologists in the process of diagnosis a qualified second opinion. For our product development, we use ModernDeeplearning procedures that the core of the Ki-supported medical image analysis images. Our KI software analyzes MRI recordings of the prostate. It supports tradiologists in the detection of lesions and thus in the diagnosis of prostate cancer. The intelligent software can be integrated into existing diagnostic software systems. The advantages: • Automated process • Time savings • Cost reduction per patient • Fast information provision for patients • Radiologists can learn from the expertise of other radiologists enhanced effectiveness: • Time and cost savings, since the radiologen automatically an annotation of prostate obtained, confirming you be able. • As a result, patients per unit of time can use the MRI. Conclusion: We offer radiologists a tool for the faster and targeted annotation of the prostate. The Ki-based software can support radiologists with faster and targeted diagnoses. The KI software is expected to be on the market in the second quarter of 2022. Further services: We are a broad contractor for companies from medicine, medical technology and pharmacy. Appears with us a free workshop! We develop and certify medical apps. We support companies in Health Marketing. We are specialists for regulatory affairs. We evaluate with Data Science company data. We develop Ki-based pose and face recognition. We use blockchain in the healthcare sector. We provide support in bioinformatics. We are partners of research.

Share
Shareable draft
Get Involved in FUSE-AI

Company Info

Founded
2017
Website
fuse-ai.de/

Categories

AI / MLMen's Health

Disease Areas

Technologies

AI/Machine LearningMedical Image AnalysisRadiology AISoftware Platform
Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of FUSE-AI?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in FUSE-AI
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free